Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Solid Tumours × Other solid neoplasm × Clear all

Phase

Status

Completed 19 Recruiting 5 Terminated 3 Unknown 1 Not yet recruiting 1 No longer available 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Advanced Solid Tumors 30 Advanced Solid Tumor 23 Solid Tumors 18 Solid Tumor 16 Mesothelioma, Malignant 8 Advanced Malignant Solid Tumor 7 Solid Tumor Cancer 5 Mesothelioma 5 Solid Tumor, Adult 3 Solid Tumor Malignancies 3 Malignant Solid Tumors 3 Advanced Malignant Solid Tumors 3 Solid Tumors, Adult 2 Ovarian Neoplasms 2 Metastatic Solid Tumors 2 Malignant Solid Neoplasm 2 Locally Advanced or Metastatic Solid Tumors 2 Hematopoietic and Lymphatic System Neoplasm 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Advanced Solid Tumor Cancer 2 Unresectable Solid Tumors 1 Unresectable Locally Advanced or Metastatic Solid Tumors 1 Triple Negative Breast Neoplasms 1 Treatment-Refractory Solid Tumors 1 Solid Tumours 1 Solid Tumors with FGFR2 Alterations, Adult 1 Solid Tumors (Phase 1) 1 Solid Tumor, Malignant Ascites 1 Solid Tumor Refractory to Conventional Treatment 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07446855 2026-03-03

PARTHENON

AstraZeneca

Phase 1/2 Not yet recruiting

Other solid neoplasm

Solid Tumours

Data powered by HemOnc (CC BY 4.0) Colophon ⚡